Addex Therapeutics Ltd.
ADXNNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for ADXN. That does not mean none is planned.
Get an email about ADXN's next catalysts
Track Addex Therapeutics (ADXN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
ADXN Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
ADX10059
Gastroesophageal Reflux
ADX48621
Parkinson's Disease
Dipraglurant
Blepharospasm
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ADX10059 | Phase 2 | Gastroesophageal Reflux | - | - |
ADX48621 | Phase 2 | Parkinson's Disease | - | - |
Dipraglurant | Phase 2 | Blepharospasm | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Addex Therapeutics Ltd.'s drug pipeline?β
CatalystAlert tracks 3 drug candidates in Addex Therapeutics Ltd.'s (ADXN) pipeline across Phase 2. Its lead program is ADX10059 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Addex Therapeutics Ltd.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Addex Therapeutics Ltd. (ADXN) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track ADXN biotech catalysts?β
Add ADXN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Addex Therapeutics Ltd.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
